Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-26

Clinical Trial Update: Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma

View source ↗

Summary

Observational study update on the long-term effect of latanoprost in normal tension glaucoma has been completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Low Tension Glaucoma | Status: COMPLETED | Results posted: 2010-10-26